Search

You searched for "tear"

2438 results found

Mainline Instruments at 100%

26 January 2026 | Company Profiles, Awards, Conferences & Anniversaries
Visit Mainline Instruments at STAND J20 during 100% Optical 2026 for an exciting programme of interactive workshops and expert-led lectures on the latest eye care innovations. Highlights include Ultra-Widefield Confocal Imaging, Dry Eye assessment, Tomography, and more. Don’t miss our...

Rb-NET: a network to save life and preserve vision in children in Africa

1 April 2018 | | EYE - Pathology, EYE - Oncology
Responding to need is a key element underpinning the VISION 2020 LINKS Programme [1]. It is embedded in the process through which LINKS are established, with institutions in low- and middle-income countries (LMICs) first defining their priority areas of training...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Contract signed to build Oriel, a state-of-the-art eye health centre

1 March 2023
A £300 million contract has been awarded to Bouygues UK to build Oriel, a new eye care, research and education centre in Camden.

Better eye health would boost UK economy by £10bn - almost double the value of the UK’s film and TV industry, research finds

12 October 2023 | IAPB, UK economy, workforce, eye health, world sight day, love your eyes
Better eye health would bring a £10 billion boost to the UK economy each year, almost twice the value of the TV and film industry, new research released this World Sight Day has found.

Thousands of retired staff return to the NHS

26 October 2023 | NHS, staff, workforce, HCP, Long Term Workforce Plan, Navina Evans, Ruth May, Will Quince
More than a third of nurses who retired two years ago had returned to practice 12 months later, according to new NHS England figures.

Registration live for 100% Ophthalmology 2025

19 September 2024 | ophthalmology, events, conferences, industry, 100%, 100% Optical, 100% ophthalmology, London, meetings
Organisers of 100% Optical have announced that visitor registrations for 100% Ophthalmology 2025 are now live for the show set to take place at London’s ExCeL from 1–3 March. Featuring as a co-located event with 100% Optical, 100% Ophthalmology, a...

The Worshipful Company of Spectacle Makers rewards early career research

16 October 2024 | research, awards, opportunities, optometry, opticians, glaucoma, retina, AI, OCT
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...

Strabismus and ocular motility, demystified

3 April 2024 | | EYE - Paediatrics, EYE - Strabismus, EYE - General
I am a former orthoptist, now trained in medicine and working as a foundation doctor. In my previous work, I was frequently approached by ophthalmology trainees eager for guidance with strabismus and ocular motility. Drawing on my clinical experience, I...

Brain tumours in adults: the essentials for an ophthalmologist

1 August 2019 | | EYE - Neuro-ophthalmology, EYE - General
The author provides a review of the common intracranial tumours in adults (other than pituitaries) which may present to an ophthalmologist. Primary malignant brain tumours comprise 3% of adult cancers but with an ageing population such tumours are becoming more...

WATCH: Novel imaging technology reveals role of immune cells in early diabetic cataract development

6 June 2023 | cataract, diabetic cataract, research
In this video interview, Proffessor Ali Hafezi-Moghadam and Professor Dr. Christoph Rußmann discuss their findings on the role of immune cells in early diabetic cataract development.

LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation

1 February 2024 | ISS, retinal, artificial, LambdaVision, industry, innovation, retinitis pigmentosa, RP
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...